市場調查報告書
商品編碼
1565773
全球獸用皮膚科藥物市場 2024-2031Global Veterinary Dermatology Drugs Market 2024-2031 |
獸用皮膚科藥物市場規模、佔有率及趨勢分析報告,按類型(抗真菌藥物、抗菌藥物和抗寄生蟲藥物)、動物類型(伴侶動物和家畜動物)、給藥途徑(局部、口服和注射) 、配銷通路(醫院藥房、零售和電子商務)和適應症(寄生蟲感染、過敏感染等)預測期(2024-2031)
預計在預測期內(2024-2031 年),獸用皮膚科藥物市場將以 9.2% 的複合年成長率成長。嚴重疾病影響全世界許多動物,例如自體免疫性皮膚病、寄生蟲皮膚病、皮屑相關皮膚病、脫髮和內源性皮膚感染。這導致對獸用皮膚病藥物的需求增加。市場成長也歸因於全球人口擴大收養寵物。這對伴侶動物照護服務和藥物的激增做出了積極貢獻。寵物皮膚病負擔的增加也促進了該行業的成長。此外,市場參與者正積極投資研發,推動市場成長。
Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report by Type (Antifungal Drugs, Antibacterial Drugs, and Antiparasitic Drugs), by Animal Type (Companion Animals and Livestock Animals), by Route of Administration (Topical, Oral, and Injectable), Distribution Channel (Hospital Pharmacies, Retail, and E-commerce), and by Indication (Parasitic Infections, Allergic Infections, and Others) Forecast Period (2024-2031)
Veterinary dermatology drugs market is anticipated to grow at a CAGR of 9.2% during the forecast period (2024-2031). Severe diseases affect a lot of animals worldwide, such as autoimmune skin diseases, parasite skin diseases, dander-related skin disorders, alopecia, and intrinsic skin infections. This is leading to an increased demand for veterinary dermatology drugs. The market growth is also attributed to the rising adoption of pets among the global population. This has positively contributed to the surge in the services and medicines available for companion animal care. The increasing burden of dermatological diseases in pet animals is also contributing to the industry's growth. Furthermore, the market players are actively investing in R&D fueling the market growth.
Market Dynamics
Increasing Pet Ownership
There has been an increase in demand for veterinary dermatology drugs in recent times owing to the growing consciousness of pet owners about the welfare and health of their animals. Moreover, an increasing number of pet owners are recognizing the worth of good skin, and there are greater success levels in treating skin diseases in animals because of advances in veterinary medicine. This is worsened by issues such as climate change and pollution, making it necessary to provide broader access to veterinary treatment that includes enhanced skin special services. Online communities and social media platforms have also contributed to the flow of information and experiences between pet owners, thereby elucidating the pattern.
Rising Skin Diseases in Pets
There are complex connections among various factors such as infections, environmental changes, and parasites that have led to the increase in cases of skin diseases affecting domestic animals including pets and livestock. Parasites, for instance, fleas as well as allergens found in food can make animals develop inflammations such as dermatitis.
Market Segmentation
Our in-depth analysis of the global veterinary dermatology drugs market includes the following segments type, animal type, route of administration, distribution channel, and indication.
Companion Animal is projected to Emerge as the Largest Segment
The rise in pet ownership has consequently led to an increased need for high-quality pet products and services. This rise has been fueled by an increased understanding of pet requirements due to advancements in veterinary medicine as well as information dissemination on the subject matter. Owners are rendering high preference for high-end pet foods, toys, and other health-related items for animals.
Topical segment to hold a Considerable Market Share
Topical medicines provide high specificity and can be easily applied directly at the affected site without having to be injected into bloodstreams thereby minimizing general body reactions or alterations from other drug elements. Veterinaries prefer topical drugs as they are easier to administer in comparison to oral tablets and suspensions. They deliver faster relief when used on the affected spot and are useful for treating several skin conditions. As consumer need for effective therapy choices rises, the topical segment is leading the way in terms of animal health care solutions innovation focusing on efficacy, safety, as well as ease of use.
The global veterinary dermatology drugs market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Holds Major Market Share
A larger number of pet owners in North America emphasize specific types of medical care such as dermatological procedures. Consequently, the rise in chemical cures that meet specific demands has been very high. Thus, pharmaceutical enterprises have been involved in research activities to design new drugs to fight against various animal skin illnesses.
The major companies serving the global veterinary dermatology drugs market include Bimeda, Inc., Ceva Sante Animale, Elanco, Merck & Co., Inc., and Zoetis Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in January 2021, Ceva Animal Health, LLC launched a new skincare brand known as Douxo S3 Pyo for cats and dogs. It is intended to offer a simple way of using antibacterial to enhance moisture content & barrier function in their ecosystem.